Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp. (BCTX) Stock Ticker

NASDAQ: BCTX · Healthcare · Biotechnology
$4.32+0.82%
USD · as of 2026-09-27 · market cap $37.5M
Open BCTX in TickrDownload for iPhone

BCTX right now

44% of the float is sold short.
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full BCTX picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on BCTX
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is currently undergoing Phase I/IIa clinical investigation. This crucial study evaluates its effectiveness when utilized in conjunction with immune checkpoint inhibitors for treating breast cancer. Beyond its flagship program, BriaCell has forged a collaborative research and development partnership with the National Cancer Institute (NCI). This alliance is dedicated to progressing Bria-OTS, a personalized immunotherapy designed for advanced breast cancer patients, and BriaDx, a proprietary diagnostic assay. The company's main offices are situated in West Vancouver, Canada.

BCTX stock facts

Ticker symbolBCTX
ExchangeNASDAQ Capital Market
SectorHealthcare
IndustryBiotechnology
Market cap$37.5M
CEOWilliam V. Williams
Employees16
HeadquartersWest Vancouver, BC, CA
IPO date2012-03-14
Websitewww.briacell.com

What you can see for BCTX on Tickr

Live BCTX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the BCTX report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for BriaCell Therapeutics Corp.?

The ticker symbol for BriaCell Therapeutics Corp. is BCTX, listed on the NASDAQ Capital Market.

What is BCTX?

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is currently undergoing Phase I/IIa clinical investigation. This crucial study evaluates its effectiveness when utilized in conjunction with immune checkpoint inhibitors for treating breast cancer.…

HomeExploreMarketLists
All pages